Lung Institute's Innovative Stem Cell Procedure is Giving End Stage Lung Disease Patients a New Option
Tampa, Florida (PRWEB) April 10, 2014 -- One year ago, Gary Oberschlake was diagnosed with idiopathic pulmonary fibrosis (IPF), a deadly lung disease with no known cause characterized by the permanent scarring of lung tissue. Gary wasn’t alone – approximately 48,000 others received the same diagnosis last year. Claiming the lives of nearly 40,000 individuals annually, IPF is as deadly as breast cancer.
Doctors told Gary, a family man with a wife, four children, and four grandchildren, his only treatment option was a double lung transplant. Knowing the inherent risks associated with this procedure, including his body’s rejection of the new lungs, Gary refused to accept it as his only chance for survival.
After spending considerable time researching possible alternative options, Gary became fascinated by recent developments in stem cell medicine, and its potential for treating sufferers of chronic lung disease like IPF. His excitement regarding this option was met with doubt expressed by his pulmonologist, who didn’t see the clinical viability of stem cells for lung conditions at the time. Despite his doctor’s reluctance, Gary decided to give stem cell therapy a chance.
According to his wife Debra, when he found Lung Institute in Tampa, FL, it was “like it was meant to be.” And, feeling as though it was a sign he couldn’t ignore, Gary made the decision to pursue autologous stem cell treatment at Lung Institute in Tampa.
Today, nine months after receiving his first treatment at Lung Institute, Gary has seen results that have far exceeded his expectations, leaving his pulmonologist and cardiologist in disbelief. In fact, all the doctors he saw after his treatments have been shocked by his positive progression, which has completely changed their perspective on his prognosis and the viability of stem cells for lung disease in general.
Their astonishment at the treatment’s overwhelming success is not unusual – many doctors like them are skeptical of the clinical application of stem cells for lung disease, simply because advancements in the field have been so recent. But skeptics need only witness the success of these treatments, as Gary’s doctors did, to have their position turned upside down.
Gary says prior to his stem cell treatment, his cardiologist said “the next time he’d see me would be in a hospital bed.” Quite to the contrary, Gary is now able to enjoy many aspects of life that were previously limited by his condition. In his words, “I’ve been able to do things with [my grandchildren]. Before I was only able to sit down and watch them.”
As a result of his refusal to accept his original prognosis, Gary and his wife are now “looking into the future and planning ahead.” Lung Institute continues to produce positive results, much like those experienced by Gary, and in doing so, is changing the lives of many suffering from chronic and debilitating pulmonary conditions.
About Lung Institute
At Lung Institute (LI), we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook or call us today at 1-855-469-5864.
Kellie Hero, [email protected], http://lunginstitute.com/, +1 (813) 503-8698, [email protected]
Share this article